#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Fifty-five year old man with thrombocytopaenia and life threatening diffuse alveolar haemorrhage. Case report


Authors: T. Karvunidis 1;  M. Harazím 1;  J. Raděj 1;  P. Salaj 2;  J. Horák 1;  I. Novák 1;  M. Matějovič 1
Authors‘ workplace: Jednotka intenzivní péče, I. interní klinika FN Plzeň a LF v Plzni, Univerzita Karlova v Praze 1;  Ústav hematologie a krevní transfuze, Praha 2
Published in: Anest. intenziv. Med., 27, 2016, č. 3, s. 170-176
Category: Intesive Care Medicine - Case Report

Overview

This case report presents a patient with acute respiratory failure due to life-threatening haemoptysis resulting from severe and refractory thrombocytopenia. It presents the diagnostics, differential diagnostics and management of such illness.

KEYWORDS:
thrombocytopaenia – haemoptysis – respiratory failure – intensive care


Sources

1. Abrahamson, P. E., Hall, S. A., Feudjo-Tepie, M., Mitrani-Gold, F. S., Logie, J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur. J. Haematol., 2009, 83, 2, p. 83–89.

2. Terrell, D. R., Beebe, L. A., Vesely, S. K., Neas, B. R., Segal, J. B., George, J. N. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am. J. Hematol., 2010, 85, 3, p. 174–180.

3. Schoonen, W. M., Kucera, G., Coalson, J., Li, L., Rutstein, M., Mowart, F., Fryzek, J., Kaye, J. A. Epidemiology of immune thrombocytopenic purpura in General Practice Research Database. Br. J. Haematol., 2009, 145, 5, p. 235–244.

4. Cines, D. B., Blanchette, V. S. Immune thrombocytopenic purpura. N. Engl. J. Med., 2002, 346, 19, p. 995–1008.

5. Cines, D. B., Liebman, H., Stasi, R. Pathobiology of secondary immune thrombocytopenia. Semin. Hematol., 2009, 46, 1, Suppl. 2, p. 2–14.

6. DiMaggio, D., Anderson, A., Bussel, J. B. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br. J. Haematol., 2009, 146, 1, p. 104–112.

7. Zhang, W., Nardi, M. A., Borkowsky, W., Li, Z., Karpatkin, S. Role of molecular mimicry of hepatitis C virus with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood, 2009, 113, 7, p. 4086–4093.

8. Ustun, C., Dainer, P., Hendricks, L., Bruker, C. T., Burgess, R. Association of breast cancer and immune thrombocytopenic purpura. South Med. J., 2002, 95, 1, p. 1335–1337.

9. Perricone, C., Ceccarelli, F., Nesher, G., Borella, E., Odeh, Q., Conti, F., Schoenfeld, Y., Valesini, G. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol. Res., 2014, 60, 2–3, p. 226–235.

10. Aster, R. H., Curtis, B. R., McFarland, J. G., Bougie, D. W. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J. Thromb. Haemost., 2009, 7, 6, p. 911–918.

11. Neunert, C., Noroozi, N., Norman, G., Buchanan, G. R., Goy, J., Nazi, I., Kelton, J. G., Arnold, D. M. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J. Thromb. Haemost., 2015, 13, 3, p. 457–464.

12. Moulis, G., Palmaro, A., Montastruc, J. L. et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood, 2014, 124, 22, p. 3308–3315.

13. McMillan, R. The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura. Curr. Hematol. Rep., 2005, 4, 2, p. 160–165.

14. Toltl, L. J., Arnold, D. M. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matter. Br. J. Haematol., 2011, 152, 1, p. 52–60.

15. Cortelazzo, S., Finazzi, G., Buelli, M., Molteni, A., Viero, P., Barbiu, T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood, 1991, 77, 1, p. 31–33.

16. Goel, R., Ness, P. M., Takemoto, C. M., Krishnamurti, L., King, K. E., Tobian, A. A. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood, 2015, 125, 9, p. 1470–1476.

17. Ghanima, W., Godeau, B., Cines, D. B., Bussel, J. B. HowI treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood, 2012, 120, 5, p. 960–969.

18. George, J. N. Management of patients with refractory immune thrombocytopenic purpura. J. Thromb. Haemost., 2006, 4, 8, p. 1664–1672.

19. Braendstrup, P., Bjerrum, O. W., Nielsen, O. J. et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am. J. Hematol., 2005, 78, 4, p. 275–280.

20. Neylon, A. J., Saunders, P. W., Howard, M. R., Proctor, S. J., Taylor, P. R. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br. J. Haematol., 2003, 122, 6, p. 966–974.

21. McMillan, R., Durette, C. Long-term outomes in adults with chronic ITP after splenectomy failure. Blood, 2004, 104, 4, p. 956–960.

22. Portielje, J. E., Westendrop, R. G., Kliun-Nelemans, H. C., Brand, A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood, 2001, 97, 9, p. 2549–2554.

23. Karpatkin, S. Autoimmune thrombocytopenic purpura. Blood, 1980, 56, 3, p. 329–343.

24. Keeling, D. M., Isenberg, D. A. Haematological manifestation of systemic lupus erythematosus. Blood Rev., 1993, 7, 4, p. 199–207.

25. Newman, K., Owlia, M. B., El-Hemaidi, I., Akhtari, M. Management of immune cytopenias in patients with systemic lupus erythematosus – old and new. Autoimmun. Rev., 2013, 10, 1, p. 784–791.

26. Liebman, H. Other immune thrombocytopenias. Semin. Hematol., 2007, 44, 4, Suppl. 5, p. 24–34.

Labels
Anaesthesiology, Resuscitation and Inten Intensive Care Medicine
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#